Animal Healthcare Market: Global Market Size, Dynamics, Regional Share, Trends, Competitor Analysis 2016 to 2021 and Forecast 2022 to 2028

$ PRICE - $ 3,000.00$ 8,900.00

Animal Healthcare Market: By Product (Vaccines, Anti-infectives, Antibiotics, Parasiticides, Feed Additives, Others), By Animal (Pets, Poultry, Ruminants, Swine, Others), and Geography

 

$ PRICE - $ 3,000.00$ 8,900.00
Clear selection
Clear
$ PRICE - $ 3,000.00$ 8,900.00
FacebookTwitterLinkedinEmail

Report

Description

The animal healthcare market is estimated to be valued at USD 64,376.3 million in 2021 and is poised to grow at a significant CAGR of 8.5% over 2022-2028. The growth in prevalence of livestock diseases coupled with a rise in R&D for the development of novel therapeutics and vaccines are key factors surge the growth of market. The vaccines segment anticipated to grow at significant CAGR over the forecast years owing to increased demand for vaccines for pet animals and livestock species coupled with launch of newer products by the market players. For instance, in May 2021, Boehringer Ingelheim India launched poultry vaccine VAXXITEK® HVT+IBD, an innovative recombinant single shot vaccine, ensuring life-long protection for all types of production chickens, namely broiler, layer and breeder. Moreover, outbreak of newer livestock disease create opportunity for the players to enhance their revenue in animal healthcare market. For instance, According to the World Health Organization (WHO), West Nile virus, a single-stranded RNA virus, can cause significant illness and death in horses. Furthermore, an improved animal healthcare system that enables early disease diagnosis and treatment will boost the pharmaceutical segment’s growth. Increase in demand for medicated and non-medicated feed additives, rise in consumption of meat, milk, and other animal products, and growing consumer awareness of animal welfare are a few factors driving the industry’s growth over the forecasting period.

Recent Market Developments:

In July 2019, Ceva Santé Animale acquired IDT Biologika GmbH’s veterinary biopharmaceutical portfolio, which will help to increase their position in the market by Ceva’s product offerings.

In Feb 2020, Vetoquinol SA company announced the acquisition of Profender and Drontal product families from Elanco Animal Health.

Animal Healthcare Market

MARKET SUMMARY
-
8.5% CAGR
  • Study Period– 2022 – 2028
  • Base Year– 2021
  • CAGR– 8.5%
  • Largest Market– North America
  • Fastest Growing Market– Asia

Animal Healthcare Market

  • The report on global animal healthcare market gives historical, current, and future market sizes (US$ Bn) on the basis of product type, by animal type, dosage form, distribution channel and geography.
  • animal healthcare market report gives comprehensive outlook across the region with special emphasis on key regions such as North America, Europe, Asia Pacific, Latin America and Middle East and Africa.
Key Players
  • Boehringer Ingelheim Gmbh,
  • Zoetis Inc.,
  • Elanco,
  • Merck & Co. Inc.,
  • Bayer Animal Health,
  • Virbac SA,
Animal Healthcare Market

Dynamics

The rising prevalence of zoonotic disease is anticipated to boost the market for animal healthcare. For instance, Equine Herpes Virus-1 (EHV-1) outbreaks have been reported in several counties in California and 26 horses have been confirmed positive in this region. Three EHM cases (EHV-1 positive with neurologic signs) and 23 EHV-1 fever-only cases have been confirmed. Moreover, in 2022, Deadly viral outbreak of EHV-1 in Europe ravages European horses. At least 17 animals have since died and others have had abortions or needed surgery to repair organ damage. Moreover, rise in awareness about the vaccination among the livestock farmers, grow in demand for quality food products, and increase in animal healthcare expenditure are immense boost to the market over the forecast period.


North-America got significant share

Animal Healthcare Market

The Animal Healthcare market in North America is likely to hold the highest revenue share of in 2021 and same trend is expected over the forecast period due to wide range of concrete initiatives taken by government for animal welfare groups that are continually trying to improve animal health. Furthermore, rapid R&D activities, increase in the number of pet owners, and an increase in the frequency of zoonotic diseases are likely to drive market expansion in this nation. Moreover, Asia pacific market is expected to grow in the forecasting period due to players are expanding their market presence, strategic alliances among the players such as collaborations, partnerships, agreements, mergers, and acquisitions. In July 2019, FUJIFILM Corporation established FUJIFILM VET Systems Co. Ltd. In Japan to supply various medical devices and services required for veterinary clinical practice

Latin America
Latin-America
North-America
North-America
Europe
Europe
Asia Pacific
Asia-Pacific
Middle East
Middle East

Key

Key Features of the Report

  • The report provides granular level information about the market size, regional market share, historic market (2016-2021) and forecast (2022-2028)
  • The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments, and start-up details that are actively working in the market
  • The report provides a plethora of information about market entry strategies, regulatory framework, and reimbursement scenario
Animal Healthcare Market Segmentation


Location

GEOGRAPHY

Frequently Asked Questions

2021 is the base year and 2028 is the forecast year.

The report covers the five regions and 15+ countries market data: North America (United States, Canada), Europe (Germany, France, Italy, Spain, and United Kingdom (UK), Asia Pacific (China, India, Japan, Australia & New Zealand), Latin America (Brazil, Mexico, Argentina) and Middle East and Africa (Saudi Arabia, United Arab Emirates, South Africa).

In our report, we provide 12-15 market players’ information into the report. However, based on the client’s request we will provide additional country and regional market players information as well.


Report

Table Of Content


Report

Company Profile

  • Merck Animal Health
  • Ceva Sante AnimalS
  • Vetoquinol S.A.
  • Zoetis
  • Boehringer Ingelheim GmbH
  • Elanco
  • IDEXX
  • Heska Corporation
  • Covetrus
  • DRE Veterinary
  • Mars Inc.
  • Virbac
  • Televet
  • Phibro Animal Health Corporation
  • Braun Vet Care

Description

The animal healthcare market is estimated to be valued at USD 64,376.3 million in 2021 and is poised to grow at a significant CAGR of 8.5% over 2022-2028. The growth in prevalence of livestock diseases coupled with a rise in R&D for the development of novel therapeutics and vaccines are key factors surge the growth of market. The vaccines segment anticipated to grow at significant CAGR over the forecast years owing to increased demand for vaccines for pet animals and livestock species coupled with launch of newer products by the market players. For instance, in May 2021, Boehringer Ingelheim India launched poultry vaccine VAXXITEK® HVT+IBD, an innovative recombinant single shot vaccine, ensuring life-long protection for all types of production chickens, namely broiler, layer and breeder. Moreover, outbreak of newer livestock disease create opportunity for the players to enhance their revenue in animal healthcare market. For instance, According to the World Health Organization (WHO), West Nile virus, a single-stranded RNA virus, can cause significant illness and death in horses. Furthermore, an improved animal healthcare system that enables early disease diagnosis and treatment will boost the pharmaceutical segment’s growth. Increase in demand for medicated and non-medicated feed additives, rise in consumption of meat, milk, and other animal products, and growing consumer awareness of animal welfare are a few factors driving the industry’s growth over the forecasting period.

Recent Market Developments:

In July 2019, Ceva Santé Animale acquired IDT Biologika GmbH’s veterinary biopharmaceutical portfolio, which will help to increase their position in the market by Ceva’s product offerings.

In Feb 2020, Vetoquinol SA company announced the acquisition of Profender and Drontal product families from Elanco Animal Health.

ASIA PACIFIC OFFICE

Precision Business Insights, 5th Floor, Mohan’s Elite, Opp : Bharat Petroleum Pump, Khanamet Road, Hitech City, Hyderabad – 500084

EUROPE OFFICE

Precision Business Insights, Kemp House, 152 – 160 City Road, London EC1V 2NX